Silexion Therapeutics Corp (SLXNW)
↓ Download CSVKey ratios (FY2025)
-457.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$11.63M | -$12.57M | -$4.68M | — |
| Net Income | -$11.91M | -$16.52M | -$5.11M | — |
| EPS (Diluted) | $8.96 | $394.94 | $44.23 | — |
| Total Assets | $7.21M | $2.86M | $5.26M | — |
| Total Liabilities | $4.61M | $6.85M | $2.25M | — |
| Shareholders' Equity | $2.60M | -$3.99M | $3.00M | $7.57M |
| Cash & Equivalents | $5.99M | $1.19M | $4.59M | — |
| Operating Cash Flow | -$10.82M | -$8.40M | -$4.53M | — |
| Capital Expenditures | $9.0K | $22.0K | $12.0K | — |
| Shares Outstanding | 3.13B | 123.29M | 97.12M | — |